Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel

Biomaterials

Volumn 33, Issue 7, 2012, Pages 2310-2320

  Li, Jing ^a   Huo, Meirong ^a   Wang, Jing ^a   Zhou, Jianping ^a   Mohammad, Jumah M ^a,b   Zhang, Yinlong ^a   Zhu, Qinnv ^a   Waddad, Ayman Y ^a   Zhang, Qiang ^c  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b MUSTANSIRIYAH UNIVERSITY   (Iraq)

^c PEKING UNIVERSITY   (China)

Author keywords

Drug delivery; Glutathione; Hyaluronic acid; Paclitaxel; Polymeric micelle; Redox sensitive

Indexed keywords

GLUTATHIONES; HYALURONIC ACIDS; PACLITAXEL; POLYMERIC MICELLE; REDOX-SENSITIVE;

CYTOLOGY; DRUG DELIVERY; DRUG PRODUCTS; FLOW CYTOMETRY; MOLECULAR BIOLOGY; ORGANIC ACIDS; PEPTIDES; TUMORS;

MICELLES;

DEOXYCHOLIC ACID; FLUORESCENT DYE; GLUTATHIONE; HYALURONIC ACID; PACLITAXEL;

ANIMAL CELL; ANIMAL EXPERIMENT; AQUEOUS SOLUTION; ARTICLE; CELL TRANSPORT; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; ENDOCYTOSIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MICELLE; MOUSE; NANOFABRICATION; NEAR INFRARED SPECTROSCOPY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; DEOXYCHOLIC ACID; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FEMALE; FLUORESCENT DYES; GLUTATHIONE; HUMANS; HYALURONIC ACID; MATERIALS TESTING; MICE; MICELLES; MICROSCOPY, ATOMIC FORCE; MOLECULAR STRUCTURE; NEOPLASMS, EXPERIMENTAL; OXAZINES; OXIDATION-REDUCTION; PACLITAXEL;

MUS;

EID: 84855722431     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.11.022     Document Type: Article

References (39)

1. Kataoka K., Harada A., Nagasaki Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Deliv Rev 2001, 47:113-131.
2. Torchilin V.P. Multifunctional nanocarriers. Adv Drug Deliv Rev 2006, 58:1532-1555.
3. Sokolsky-Papkov M., Agashi K., Olaye A., Shakesheff K., Domb A.J. Polymer carriers for drug delivery in tissue engineering. Adv Drug Deliv Rev 2007, 59:187-206.
4. Cheng R., Feng F., Meng F., Deng C., Feijen J., Zhong Z. Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery. JControl Release 2011, 152:2-12.
5. Ikada Y., Tsuji H. Biodegradable polyesters for medical and ecological applications. Macromol Rapid Commun 2000, 21:117-132.
6. Shuai X., Ai H., Nasongkla N., Kim S., Gao J. Micellar carriers based on block copolymers of poly(epsilon-caprolactone) and poly(ethylene glycol) for doxorubicin delivery. JControl Release 2004, 98:415-426.
7. Fang J., Nakamura H., Maeda H. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev 2011, 63:136-151.
8. Meng F., Hennink W.E., Zhong Z. Reduction-sensitive polymers and bioconjugates for biomedical applications. Biomaterials 2009, 30:2180-2198.
9. Gilbert H.F. Thiol/disulfide exchange equilibria and disulfide bond stability. Methods Enzymol 1995, 251:8-28.
10. Raina S., Missiakas D. Making and breaking disulfide bonds. Annu Rev Microbiol 1997, 51:179-202.
11. Balendiran G.K., Dabur R., Fraser D. The role of glutathione in cancer. Cell Biochem Funct 2004, 22:343-352.
12. Schafer F.Q., Buettner G.R. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 2001, 30:1191-1212.
13. Sun H., Guo B., Cheng R., Meng F., Liu H., Zhong Z. Biodegradable micelles with sheddable poly(ethylene glycol) shells for triggered intracellular release of doxorubicin. Biomaterials 2009, 30:6358-6366.
14. Sun Y., Yan X., Yuan T., Liang J., Fan Y., Gu Z., et al. Disassemblable micelles based on reduction-degradable amphiphilic graft copolymers for intracellular delivery of doxorubicin. Biomaterials 2010, 31:7124-7131.
15. Sun P., Zhou D., Gan Z. Novel reduction-sensitive micelles for triggered intracellular drug release. JControl Release 2011, 155:96-103.
16. Wen H.Y., Dong H.Q., Xie W.J., Li Y.Y., Wang K., Pauletti G.M., et al. Rapidly disassembling nanomicelles with disulfide-linked PEG shells for glutathione-mediated intracellular drug delivery. Chem Commun (Camb) 2011, 47:3550-3552.
17. Kuppusamy P., Li H., Ilangovan G., Cardounel A.J., Zweier J.L., Yamada K., et al. Noninvasive imaging of tumor redox status and its modification by tissue glutathione levels. Cancer Res 2002, 62:307-312.
18. Soderberg A., Sahaf B., Rosen A. Thioredoxin reductase, a redox-active selenoprotein, is secreted by normal and neoplastic cells: presence in human plasma. Cancer Res 2000, 60:2281-2289.
19. Bauhuber S., Hozsa C., Breunig M., Gopferich A. Delivery of nucleic acids via disulfide-based carrier systems. Adv Mater 2009, 21:3286-3306.
20. Kurz T., Eaton J.W., Brunk U.T. Redox activity within the lysosomal compartment: implications for aging and apoptosis. Antioxid Redox Signal 2010, 13:511-523.
21. Knudson C.B., Knudson W. Cartilage proteoglycans. Semin Cell Dev Biol 2001, 12:69-78.
22. Knudson C.B., Knudson W. Hyaluronan-binding proteins in development, tissue homeostasis, and disease. FASEB J 1993, 7:1233-1241.
23. Entwistle J., Hall C.L., Turley E.A. HA receptors: regulators of signalling to the cytoskeleton. JCell Biochem 1996, 61:569-577.
24. Herrlich P., Sleeman J., Wainwright D., Konig H., Sherman L., Hilberg F., et al. How tumor cells make use of CD44. Cell Adhes Commun 1998, 6:141-147.
25. Hall C.L., Yang B., Yang X., Zhang S., Turley M., Samuel S., et al. Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformation. Cell 1995, 82:19-26.
26. Oh E.J., Park K., Kim K.S., Kim J., Yang J.A., Kong J.H., et al. Target specific and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivatives. JControl Release 2010, 141:2-12.
27. Lee H., Mok H., Lee S., Oh Y.K., Park T.G. Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels. JControl Release 2007, 119:245-252.
28. Yeom J., Chang S., Park J.K., Je J.H., Yang D.J., Choi S.K., et al. Synchrotron X-ray bioimaging of bone regeneration by artificial bone substitute of MegaGen Synthetic Bone and hyaluronate hydrogels. Tissue Eng Part C Methods 2010, 16:1059-1068.
29. Pouyani T., Prestwich G.D. Functionalized derivatives of hyaluronic acid oligosaccharides: drug carriers and novel biomaterials. Bioconjug Chem 1994, 5:339-347.
30. Luo Y., Prestwich G.D. Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate. Bioconjug Chem 1999, 10:755-763.
31. Ki Y.C., Kyung H.M., Jin H.N., Kuiwon C., Kwangmeyung K., Jae H.P., et al. Self-assembled hyaluronic acid nanoparticles as a potential drug carrier for cancer therapy: synthesis, characterization, and invivo biodistribution. JMater Chem 2009, 19:4102-4107.
32. Haque Z. Kito M. Lipophilization of soybean glycinin: covalent attachment to long chain fatty acids. Agr Biol Chem 1982, 46:597-599.
33. Habeeb A.F. Asensitive method for localization of disulfide containing peptides in column effluents. Anal Biochem 1973, 56:60-65.
34. Soga O., van Nostrum C.F., Fens M., Rijcken C.J., Schiffelers R.M., Storm G., et al. Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery. JControl Release 2005, 103:341-353.
35. He G., Ma L.L., Pan J., Venkatraman S. ABA and BAB type triblock copolymers of PEG and PLA: a comparative study of drug release properties and "stealth" particle characteristics. Int J Pharm 2007, 334:48-55.
36. Chan J.M., Zhang L., Yuet K.P., Liao G., Rhee J.W., Langer R., et al. PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery. Biomaterials 2009, 30:1627-1634.
37. Choi K.Y., Chung H., Min K.H., Yoon H.Y., Kim K., Park J.H., et al. Self-assembled hyaluronic acid nanoparticles for active tumor targeting. Biomaterials 2010, 31:106-114.
38. Greenspan P., Mayer E.P., Fowler S.D. Nile red: a selective fluorescent stain for intracellular lipid droplets. JCell Biol 1985, 100:965-973.
39. Santini M.T., Romano R., Rainaldi G., Filippini P., Bravo E., Porcu L., et al. The relationship between 1H-NMR mobile lipid intensity and cholesterol in two human tumor multidrug resistant cell lines (MCF-7 and LoVo). Biochim Biophys Acta 2001, 1531:111-131.